Mundipharma AB Information

Mundipharma A/B is a Sweden-based pharmaceutical company that collaborates with pharma and biotech companies throughout the world. We are part of Purdue/Mundipharma/Napp – an international network of independent associated pharmaceutical companies. The privately-owned network operates in the global pharmaceutical market in 51 countries and has more than 8,000 employees throughout the world. Established in 1998, constant innovation to improve the quality of patients’ lives has always been key to everything we do. We continuously seek new ways to improve treatments and reduce symptoms in all our areas of expertise, from headlice elimination to the treatment of serious cancers. We understand that research is vital to finding new and better treatment methods. So we support senior researchers, specialists and PhD undergraduates that work within our core areas, and we also collaborate with researchers at Sweden’s universities and hospitals. We are located in Göteborg, and our team consists of the brightest entrepreneurial minds from the pharmaceutical industry. This enables us and our partners to achieve approvals, develop go-to-market strategies and establish strong market positions for medicines and medical devices on the Swedish market. Our operations in the Nordic region – Denmark, Sweden, Norway, Finland and Iceland – are part of the international network of Mundipharma’s independent associated companies. We collaborate with innovation partners throughout the Nordic region, Europe and the rest of the world. Our success is based on the commitment of our people and our shared passion for improving the health and quality of life of people everywhere. We are ‘Entrepreneurs driven by Passion’.